false--02-23Q220182018-09-080001646972falseNon-accelerated Filerfalse17000000.010.01100000000010000000002796540282796540282796540282796540280.0870.07450.05340.06520.03950.04320.066250.057506000000142000000.010.0130000000300000000000 0001646972 2018-02-25 2018-09-08 0001646972 2018-10-18 0001646972 2018-02-24 0001646972 2018-09-08 0001646972 2017-06-18 2017-09-09 0001646972 2018-06-17 2018-09-08 0001646972 2017-02-26 2017-09-09 0001646972 2017-02-25 0001646972 2017-09-09 0001646972 us-gaap:AccountingStandardsUpdate201707Member 2018-02-25 2018-09-08 0001646972 us-gaap:PredecessorMember 2017-06-18 2017-09-09 0001646972 2017-12-03 2018-02-24 0001646972 aci:PharmacyMember 2018-09-08 0001646972 us-gaap:AccountingStandardsUpdate201409Member us-gaap:RetainedEarningsMember 2018-02-25 0001646972 aci:PharmacyMember 2018-02-24 0001646972 us-gaap:AccountingStandardsUpdate201618Member 2017-02-26 2017-09-09 0001646972 us-gaap:PredecessorMember 2017-06-30 2017-06-30 0001646972 us-gaap:AccountingStandardsUpdate201707Member 2018-06-17 2018-09-08 0001646972 aci:NonPerishablesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-06-17 2018-09-08 0001646972 aci:NonPerishablesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-06-18 2017-09-09 0001646972 aci:PharmacyMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-02-25 2018-09-08 0001646972 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-02-25 2018-09-08 0001646972 aci:NonPerishablesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-02-25 2018-09-08 0001646972 aci:PerishablesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-02-26 2017-09-09 0001646972 us-gaap:FuelMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-06-18 2017-09-09 0001646972 aci:PharmacyMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-02-26 2017-09-09 0001646972 aci:PerishablesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-06-18 2017-09-09 0001646972 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-02-26 2017-09-09 0001646972 aci:OtherProductsandServicesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-06-18 2017-09-09 0001646972 aci:PerishablesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-06-17 2018-09-08 0001646972 us-gaap:FuelMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-02-25 2018-09-08 0001646972 aci:OtherProductsandServicesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-06-17 2018-09-08 0001646972 us-gaap:FuelMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-02-26 2017-09-09 0001646972 us-gaap:FuelMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-06-17 2018-09-08 0001646972 aci:NonPerishablesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-02-26 2017-09-09 0001646972 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-06-17 2018-09-08 0001646972 aci:PharmacyMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-06-18 2017-09-09 0001646972 aci:OtherProductsandServicesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-02-25 2018-09-08 0001646972 aci:PharmacyMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-06-17 2018-09-08 0001646972 aci:PerishablesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-02-25 2018-09-08 0001646972 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-06-18 2017-09-09 0001646972 aci:OtherProductsandServicesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-02-26 2017-09-09 0001646972 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-08 0001646972 us-gaap:FairValueMeasurementsRecurringMember 2018-09-08 0001646972 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-08 0001646972 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-08 0001646972 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-08 0001646972 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-08 0001646972 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-08 0001646972 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2018-09-08 0001646972 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-09-08 0001646972 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-02-24 0001646972 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-09-08 0001646972 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-02-24 0001646972 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-02-24 0001646972 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-02-24 0001646972 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-02-24 0001646972 us-gaap:FairValueMeasurementsRecurringMember 2018-02-24 0001646972 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-02-24 0001646972 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-02-24 0001646972 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2018-02-24 0001646972 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-02-24 0001646972 aci:ContingentConsiderationMember 2018-02-24 0001646972 aci:ContingentConsiderationMember 2018-02-25 2018-09-08 0001646972 aci:ContingentConsiderationMember 2018-09-08 0001646972 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-02-26 2017-09-09 0001646972 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-02-25 2018-09-08 0001646972 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-06-17 2018-09-08 0001646972 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-06-18 2017-09-09 0001646972 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-08 0001646972 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-02-24 0001646972 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-02-24 0001646972 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-08 0001646972 aci:InterestRateSwapOneMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-06-20 0001646972 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-06-20 2018-06-20 0001646972 aci:InterestRateSwapTwoMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-06-20 0001646972 aci:LetterOfCreditSubFacilityMember 2018-02-24 0001646972 aci:AssetBasedLoanFacilityMember us-gaap:LineOfCreditMember 2018-09-08 0001646972 aci:FloatRateNotesMember 2018-06-25 2018-06-25 0001646972 aci:FloatRateNotesMember 2018-06-25 0001646972 aci:LetterOfCreditSubFacilityMember 2018-09-08 0001646972 srt:MaximumMember 2018-09-08 0001646972 aci:FloatRateNotesMember us-gaap:DebtInstrumentRedemptionPeriodOneMember 2018-06-25 2018-06-25 0001646972 aci:SecuredMortgageNotesPayableMember us-gaap:MortgagesMember 2018-09-08 0001646972 aci:SeniorUnsecuredNotesMaturity2024and2025Member us-gaap:SeniorNotesMember 2018-09-08 0001646972 aci:SeniorUnsecuredNotesMaturity2024and2025Member us-gaap:SeniorNotesMember 2018-02-24 0001646972 aci:NALPNotesMaturity2027To2031Member us-gaap:NotesPayableToBanksMember 2018-02-24 0001646972 aci:UnsecuredNotesPayableMember us-gaap:NotesPayableOtherPayablesMember 2018-02-24 0001646972 aci:TermLoansMaturity2021to2023Member us-gaap:SecuredDebtMember 2018-09-08 0001646972 aci:SecuredMortgageNotesPayableMember us-gaap:MortgagesMember 2018-02-24 0001646972 aci:TermLoansMaturity2021to2023Member us-gaap:SecuredDebtMember 2018-02-24 0001646972 aci:SafewayNotesMaturity2019to2031Member us-gaap:NotesPayableToBanksMember 2018-02-24 0001646972 aci:UnsecuredNotesPayableMember us-gaap:NotesPayableOtherPayablesMember 2018-09-08 0001646972 aci:SafewayNotesMaturity2019to2031Member us-gaap:NotesPayableToBanksMember 2018-09-08 0001646972 aci:NALPNotesMaturity2027To2031Member us-gaap:NotesPayableToBanksMember 2018-09-08 0001646972 aci:AssetBasedLoanFacilityMember us-gaap:LineOfCreditMember 2018-02-24 0001646972 srt:MinimumMember aci:SafewayNotesMaturity2019to2031Member us-gaap:NotesPayableToBanksMember 2018-09-08 0001646972 aci:SeniorUnsecuredNotesMaturity2024Member us-gaap:SeniorNotesMember 2018-09-08 0001646972 aci:SeniorUnsecuredNotesMaturity2025Member us-gaap:SeniorNotesMember 2018-09-08 0001646972 srt:MaximumMember aci:TermLoansMaturity2021to2023Member us-gaap:SecuredDebtMember 2018-09-08 0001646972 srt:MinimumMember aci:NALPNotesMaturity2027To2031Member us-gaap:NotesPayableToBanksMember 2018-09-08 0001646972 srt:MinimumMember aci:TermLoansMaturity2021to2023Member us-gaap:SecuredDebtMember 2018-09-08 0001646972 srt:MaximumMember aci:NALPNotesMaturity2027To2031Member us-gaap:NotesPayableToBanksMember 2018-09-08 0001646972 srt:MaximumMember aci:SafewayNotesMaturity2019to2031Member us-gaap:NotesPayableToBanksMember 2018-09-08 0001646972 us-gaap:PensionPlansDefinedBenefitMember 2018-02-25 2018-09-08 0001646972 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-02-26 2017-09-09 0001646972 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-02-25 2018-09-08 0001646972 us-gaap:PensionPlansDefinedBenefitMember 2017-02-26 2017-09-09 0001646972 us-gaap:SubsequentEventMember 2018-09-14 2018-09-14 0001646972 us-gaap:PensionPlansDefinedBenefitMember 2017-06-18 2017-09-09 0001646972 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-06-17 2018-09-08 0001646972 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-06-18 2017-09-09 0001646972 us-gaap:PensionPlansDefinedBenefitMember 2018-06-17 2018-09-08 0001646972 srt:AffiliatedEntityMember 2017-02-26 2017-09-09 0001646972 srt:AffiliatedEntityMember 2017-06-18 2017-09-09 0001646972 srt:AffiliatedEntityMember 2018-06-17 2018-09-08 0001646972 srt:AffiliatedEntityMember 2018-02-25 2018-09-08 0001646972 aci:SafewayIncMember aci:Safeways401kPlanMember us-gaap:PendingLitigationMember 2018-09-08 0001646972 aci:Mertzv.SuperValuIncandRockeV.SuperValuInc.Member us-gaap:PendingLitigationMember 2018-09-08 0001646972 aci:ABAcquisitionMember aci:SecurityBreachMember us-gaap:ThreatenedLitigationMember 2015-10-06 0001646972 aci:QuiTamLawsuitsMember us-gaap:PendingLitigationMember 2018-09-08 0001646972 aci:MasterCardLitigationMember us-gaap:SettledLitigationMember 2016-12-09 2016-12-09 0001646972 aci:MasterCardLitigationMember aci:AdditionalAssessmentsandCardReissuanceCostsMember 2018-01-02 0001646972 aci:Mertzv.SuperValuIncandRockeV.SuperValuInc.Member aci:DismissedMember 2017-08-30 2017-08-30 0001646972 aci:Mertzv.SuperValuIncandRockeV.SuperValuInc.Member us-gaap:PendingLitigationMember 2015-08-10 2015-08-10 0001646972 aci:Mertzv.SuperValuIncandRockeV.SuperValuInc.Member us-gaap:PendingLitigationMember 2017-08-30 2017-08-30 0001646972 us-gaap:AccumulatedTranslationAdjustmentMember 2017-09-09 0001646972 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-02-25 0001646972 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-02-25 0001646972 aci:AccumulatedOtherComprehensiveIncomeOtherAttributabletoParentMember 2017-02-26 2017-09-09 0001646972 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2017-02-26 2017-09-09 0001646972 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2017-09-09 0001646972 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-02-26 2017-09-09 0001646972 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2017-02-25 0001646972 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-09-09 0001646972 us-gaap:AccumulatedTranslationAdjustmentMember 2017-02-26 2017-09-09 0001646972 aci:AccumulatedOtherComprehensiveIncomeOtherAttributabletoParentMember 2017-02-25 0001646972 aci:AccumulatedOtherComprehensiveIncomeOtherAttributabletoParentMember 2017-09-09 0001646972 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-09-09 0001646972 us-gaap:AccumulatedTranslationAdjustmentMember 2017-02-25 0001646972 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-09-08 0001646972 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-09-08 0001646972 aci:AccumulatedOtherComprehensiveIncomeOtherAttributabletoParentMember 2018-02-25 2018-09-08 0001646972 us-gaap:AccumulatedTranslationAdjustmentMember 2018-02-24 0001646972 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-02-24 0001646972 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-02-25 2018-09-08 0001646972 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-02-25 2018-09-08 0001646972 us-gaap:AccumulatedTranslationAdjustmentMember 2018-09-08 0001646972 us-gaap:AccumulatedTranslationAdjustmentMember 2018-02-25 2018-09-08 0001646972 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-08 0001646972 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-02-24 0001646972 aci:AccumulatedOtherComprehensiveIncomeOtherAttributabletoParentMember 2018-02-24 0001646972 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-02-24 0001646972 aci:AccumulatedOtherComprehensiveIncomeOtherAttributabletoParentMember 2018-09-08 aci:division aci:plaintiff aci:derivative iso4217:USD xbrli:shares aci:insurance_carrier aci:incident iso4217:USD xbrli:shares aci:store_format aci:segment aci:state xbrli:pure aci:lawsuit

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

For the quarterly period ended September 8, 2018

OR

For the transition period from _____ to _____

Commission File Number: 333-205546

Registrant’s telephone number, including area code (208) 395-6200

Not applicable

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     ☐ Yes  ☒ No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   ☒ Yes  ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  ¨ Yes    x No

As of October 18, 2018, the registrant had 277,882,010 shares of common stock, par value $0.01 per share, outstanding.

Albertsons Companies, Inc. and Subsidiaries

PART I - FINANCIAL INFORMATION

Item 1 - Condensed Consolidated Financial Statements (unaudited)

Albertsons Companies, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(in millions, except share data)

(unaudited)

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Albertsons Companies, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations and Comprehensive Loss

(in millions)

(unaudited)

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Albertsons Companies, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(in millions)

(unaudited)

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Notes to Condensed Consolidated Financial Statements

(unaudited)

NOTE 1 - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying interim Condensed Consolidated Financial Statements include the accounts of Albertsons Companies, Inc. and its subsidiaries (the "Company"). All significant intercompany balances and transactions were eliminated. The Condensed Consolidated Balance Sheet as of February 24, 2018 is derived from the Company's annual audited Consolidated Financial Statements for the fiscal year ended February 24, 2018, which should be read in conjunction with these Condensed Consolidated Financial Statements and which are included in the Company's Annual Report on Form 10-K. Certain information in footnote disclosures normally included in annual financial statements was condensed or omitted for the interim periods presented in accordance with accounting principles generally accepted in the United States of America ("GAAP"). In the opinion of management, the interim data includes all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. The interim results of operations and cash flows are not necessarily indicative of those results and cash flows expected for the year. The Company’s results of operations are for the 12 and 28 weeks ended September 8, 2018 and September 9, 2017.

Prior Period Reclassifications

Certain prior period amounts have been reclassified to conform to the current period presentation, including the addition of Restricted cash to Cash and cash equivalents on the Condensed Consolidated Statements of Cash Flows, and the reclassification of non-service cost components of Net pension and post-retirement expense to Other (income) expense from Selling and administrative expenses on the Condensed Consolidated Statements of Operations and Comprehensive Loss, as a result of the adoption of new accounting guidance.

Significant Accounting Policies

Restricted cash: Restricted cash is included in Other current assets or Other assets depending on the remaining term of the restriction and primarily relates to funds held in escrow. The Company had $7.9 million and $10.5 million of Restricted cash as of September 8, 2018 and February 24, 2018, respectively.

Inventories, net: Substantially all of the Company’s inventories consist of finished goods valued at the lower of cost or market and net of vendor allowances. The Company uses either item-cost or the retail inventory method to value inventory at lower of cost or market before application of any last-in, first-out ("LIFO") reserve. Interim LIFO inventory costs are based on management's estimates of expected year-end inventory levels and inflation rates. The Company recorded LIFO expense of $3.4 million and $7.9 million for the 12 weeks ended September 8, 2018 and September 9, 2017, respectively and $12.9 million and $23.6 million for the 28 weeks ended September 8, 2018 and September 9, 2017, respectively.

Equity-based compensation: The Company maintains the Albertsons Companies, Inc. Phantom Unit Plan (the "Phantom Unit Plan"), an equity-based incentive plan, which provides for grants of Phantom Units to certain employees, directors and consultants. Each Phantom Unit provides the participant with a contractual right to receive, upon vesting, one management incentive unit in each of the Company's parents, Albertsons Investor Holdings LLC and KIM ACI, LLC, that collectively own all of the outstanding shares of the Company. The Phantom Units vest over a service period, or upon a combination of both a service period and achievement of certain performance-based thresholds. The fair value of the Phantom Units is determined using an option pricing model, adjusted for lack of marketability and using an expected term or time to liquidity based on judgments made by management. Equity-based compensation expense recognized by the Company related to these plans was $12.2 million and $9.3 million for the 12 weeks ended September 8, 2018 and September 9, 2017, respectively. For the 28 weeks ended September 8, 2018 and September 9, 2017, equity-based compensation expense was $25.6 million and $18.1 million, respectively. The Company recorded an income tax benefit of $3.3 million and $1.9 million related to equity-based compensation for the 12 weeks ended

September 8, 2018 and September 9, 2017, respectively. For the 28 weeks ended September 8, 2018 and September 9, 2017, the Company recorded an income tax benefit of $6.9 million and $3.7 million, respectively. As of September 8, 2018, there was $33.9 million of unrecognized costs related to 1.4 million unvested Phantom Units. That cost is expected to be recognized over a weighted average period of 0.9 years.

On June 30, 2017, the Company’s predecessor, Albertsons Companies, LLC, made a cash distribution of $250.0 million to its equityholders, which resulted in a modification of certain vested awards. As a result of the modification, equity-based compensation expense recognized for the 12 weeks ended September 9, 2017 includes $2.4 million of additional expense.

Income taxes: Income tax benefit was $11.9 million, or 26.8%, and $67.7 million, or 16.0%, of loss before income taxes for the 12 weeks ended September 8, 2018 and September 9, 2017, respectively. Income tax benefit was $14.9 million, or 22.9%, and $67.3 million, or 10.7%, of loss before income taxes for the 28 weeks ended September 8, 2018 and September 9, 2017, respectively. The increase in effective tax rate for the 28 weeks ended September 8, 2018 compared to the 28 weeks ended September 9, 2017 was primarily the result of the Company's corporate reorganization in the fourth quarter of fiscal 2017. Prior to the fourth quarter of fiscal 2017, the Company was organized as a limited liability company and conducted its operations primarily through limited liability companies and Subchapter C corporations. As such, the Company's effective tax rate in prior periods was largely driven by the mix of pre-tax income or loss between its taxable and nontaxable entities.

On December 22, 2017, the President signed the Tax Cuts and Jobs Act (the "Tax Act") into law, which enacted significant changes to U.S. income tax and related laws. Among other things, the Tax Act reduces the top U.S. corporate income tax rate from 35% to 21%, and makes changes to certain other business-related exclusions, deductions and credits. Also on December 22, 2017, the SEC staff issued Staff Accounting Bulletin No. 118 ("SAB 118") to address the application of GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed in reasonable detail to complete the accounting for income tax effects of the Tax Act. SAB 118 allows the Company to record provisional amounts during a measurement period not to extend beyond one year from the date of enactment. The Tax Act was effective in the fourth quarter of fiscal 2017, during which the Company recorded a provisional tax benefit of $430.4 million. The Company did not record any material adjustments to the provisional tax benefit during the 28 weeks ended September 8, 2018. As of September 8, 2018, the Company had not completed its accounting for the Tax Act. The Company continues to analyze the Tax Act and refine its calculations, which could impact the measurement of its tax balances. The Company expects to complete its analysis within the measurement period in accordance with SAB 118.

Segments: The Company and its subsidiaries offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel and other items and services in its stores or through eCommerce channels. The Company's operating divisions are geographically based, have similar economic characteristics and similar expected long-term financial performance. The Company's operating segments and reporting units are its 13 divisions, which have been aggregated into one reportable segment. Each reporting unit constitutes a business for which discrete financial information is available and for which management regularly reviews the operating results. Across all operating segments, the Company operates primarily one store format. Each store offers the same general mix of products with similar pricing to similar categories of customers, has similar distribution methods, operates in similar regulatory environments and purchases merchandise from similar or the same vendors. All of the Company's retail operations are domestic.

Revenue Recognition: Revenues from the retail sale of products are recognized at the point of sale to the customer, net of returns and sales tax. Pharmacy sales are recorded upon the customer receiving the prescription. Third party receivables from pharmacy sales were $205.0 million and $205.5 million as of September 8, 2018 and February 24, 2018, respectively, and are recorded in Receivables, net. For eCommerce related sales, which primarily includes home delivery, "Drive Up and Go" stores and Plated meal kit delivery, revenues are recognized upon either pickup in store or delivery to the customer and may include revenue for separately charged delivery services. Discounts provided to

customers by the Company at the time of sale are recognized as a reduction in sales as the products are sold. Discounts provided to customers by vendors, usually in the form of coupons, are not recognized as a reduction in sales, provided the coupons are redeemable at any retailer that accepts coupons. The Company recognizes revenue and records a corresponding receivable from the vendor for the difference between the sales prices and the cash received from the customer. The Company records a contract liability when rewards are earned by customers in connection with the Company's loyalty programs. As rewards are redeemed or expire, the Company reduces the contract liability and recognizes revenue.

The Company records a contract liability when it sells its own proprietary gift cards. The Company records a sale when the customer redeems the gift card. The gift cards do not expire. The Company reduces the contract liability and records revenue for the unused portion of gift cards ("breakage") in proportion to its customers' pattern of redemption, which the Company determined to be the historical redemption rate. The Company's contract liability related to gift cards was $43.7 million as of September 8, 2018 and $55.6 million as of February 24, 2018. Breakage amounts were immaterial for the 12 and 28 weeks ended September 8, 2018 and September 9, 2017, respectively.

Disaggregated Revenues

The following table represents sales revenue by type of similar product (dollars in millions):

(1) eCommerce related sales are included in the categories to which the revenue pertains.

(2) Consists primarily of general merchandise, grocery and frozen foods.

(3) Consists primarily of produce, dairy, meat, deli, floral and seafood.

(4) Consists primarily of lottery and various other commissions and other miscellaneous income.

Recently adopted accounting standards: In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-09, "Revenue from Contracts with Customers (Topic 606)". The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company adopted this guidance in the first quarter of fiscal 2018 on a modified retrospective basis, including implementing changes to processes and controls to comply with the new disclosure requirements. The adoption of this standard resulted in a decrease to accumulated deficit of $5.8 million. The adjustment relates to breakage on the unredeemed portion of the Company's gift cards, which are now recognized in proportion to customer redemptions of gift cards, rather than waiting until the likelihood of redemption becomes remote. Similar to previous guidance, in certain third-party arrangements where the Company had previously determined it acts as a principal versus an agent, the Company will continue to record revenue for these arrangements on a gross basis under the new guidance.

In March 2017, the FASB issued ASU 2017-07, "Compensation - Retirement Benefits (Topic 715) - Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost." The Company adopted this guidance in the first quarter of fiscal 2018 on a retrospective basis. This ASU requires an employer to report the service

cost component of net pension and post-retirement expense in the same line as other compensation costs from services rendered by employees during the period. Other components of net pension and post-retirement expense are required to be presented in the income statement separately from the service cost component. For the 12 and 28 weeks ended September 9, 2017, the Company reclassified $6.0 million and $14.2 million, respectively, of non-service pension and post-retirement cost components to Other (income) expense from Selling and administrative expenses.

In November 2016, the FASB issued ASU 2016-18, "Statement of Cash Flows - Restricted Cash (Topic 230)". The Company adopted this guidance in the first quarter of fiscal 2018 on a retrospective basis. The new guidance requires that restricted cash be added to Cash and cash equivalents when reconciling the beginning and ending amounts on the Condensed Consolidated Statements of Cash Flows. The guidance also requires entities that report cash and cash equivalents and restricted cash separately on the Condensed Consolidated Balance Sheets to reconcile those amounts to the Condensed Consolidated Statements of Cash Flows. For the 28 weeks ended September 9, 2017, the adoption of this standard resulted in a decrease to Net cash used in investing activities and an increase to Net increase (decrease) in cash and cash equivalents and restricted cash of $1.7 million. The following table provides a reconciliation of the amount of Cash and cash equivalents reported on the Condensed Consolidated Balance Sheets to the total of Cash and cash equivalents and restricted cash shown on the Condensed Consolidated Statements of Cash Flows (in millions):

In August 2017, the FASB issued ASU 2017-12, "Derivatives and Hedging (Topic 815)". The new guidance more closely aligns the results of cash flow and fair value hedge accounting with risk management activities through changes to both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedge results in the financial statements. The guidance expands hedge accounting for both nonfinancial and financial risk components and refines the measurement of hedge results to better reflect an entity’s hedging strategies. The Company elected to early adopt this ASU beginning the first day of fiscal 2018. The adoption of this guidance did not have a material impact on the Company's Condensed Consolidated Financial Statements.

In January 2016, the FASB issued ASU 2016-01, "Financial Instruments-Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities". The ASU is intended to improve the recognition and measurement of financial instruments. The Company adopted this guidance in the first quarter of fiscal 2018. The new guidance requires equity investments, other than those accounted for under the equity method, to be measured at fair value, with changes in fair value recognized in net income. The guidance also amends certain disclosure requirements associated with the fair value of financial instruments. The adoption of this guidance did not have a material impact on the Company's Condensed Consolidated Financial Statements.

In August 2018, the FASB issued ASU 2018-15, "Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)". The ASU is intended to improve the recognition and measurement of financial instruments. The new guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The Company elected to early adopt this ASU in the second quarter of fiscal 2018 on a prospective basis. The adoption of this guidance did not have a material impact on the Company's Condensed Consolidated Financial Statements.

Recently issued accounting standards: In February 2016, the FASB issued ASU 2016-02, "Leases (Topic 842)". The ASU will require organizations that lease assets to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. The new guidance will require both classifications of leases, operating and capital, to be recognized on the balance sheet. Consistent with current GAAP, the recognition, measurement and

presentation of expenses and cash flows arising from a lease will depend on its classification. The ASU also will require disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. The Company plans to adopt this guidance in the first quarter of fiscal 2019. The adoption of this ASU will result in the recognition of significant right-of-use assets and lease liabilities in the Company’s Consolidated Balance Sheets. The Company has formed a dedicated project team and developed a comprehensive multi-stage project plan to assess and implement this ASU. This assessment includes reviewing all forms of leases, analyzing practical expedients and leveraging a technology solution in implementing the new ASU. This assessment is ongoing, including the assessment of other potential impacts of this ASU on the Consolidated Financial Statements and disclosures.

In February 2018, the FASB issued ASU 2018-02, "Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income". This ASU amends ASC 220, "Income Statement - Reporting Comprehensive Income", to allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Act. In addition, under the ASU, the Company may be required to provide certain disclosures regarding stranded tax effects. The ASU will take effect for public entities for annual reporting periods beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the effect of the standard on its Consolidated Financial Statements.

NOTE 2 - ACQUISITIONS

Termination of Merger Agreement with Rite Aid

As previously disclosed, on February 18, 2018, the Company and its wholly-owned subsidiaries, Ranch Acquisition II LLC and Ranch Acquisition Corp. (together with Ranch Acquisition II LLC, "Merger Subs") and Rite Aid Corporation ("Rite Aid") entered into an Agreement and Plan of Merger (the "Merger Agreement"). On August 8, 2018, the Company, Merger Subs and Rite Aid entered into a Termination Agreement (the "Termination Agreement") under which the parties mutually agreed to terminate the Merger Agreement. Subject to limited customary exceptions, the Termination Agreement also mutually releases the parties from any claims of liability to one another relating to the contemplated merger transaction. Under the terms of the Merger Agreement, neither the Company nor Rite Aid will be responsible for any payments to the other party as a result of the termination of the Merger Agreement.

In addition, as result of the above termination, that certain Second Amended & Restated Commitment Letter, dated May 8, 2018, by and among the Company, Bank of America, N.A., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Credit Suisse AG, Credit Suisse Loan Funding LLC, Goldman Sachs Bank USA and the other commitment parties thereto terminated automatically pursuant to its terms.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

The following table presents assets and liabilities which were measured at fair value on a recurring basis as of September 8, 2018 (in millions):

(1) Primarily relates to Mutual Funds. Included in Other current assets.

(2) Primarily relates to investments in publicly traded stock classified as available for sale (Level 1) and U.S. Treasury Notes and Corporate Bonds (Level 2). Included in Other assets.

(3) Primarily relates to interest rate swaps. Included in Other current liabilities.

(4) Included in Other long-term liabilities.

The following table presents assets and liabilities which were measured at fair value on a recurring basis as of February 24, 2018 (in millions):

(1) Primarily relates to Mutual Funds. Included in Other current assets.

(2) Primarily relates to investments in publicly traded stock classified as available for sale (Level 1) and U.S. Treasury Notes and Corporate Bonds (Level 2). Included in Other assets.

(3) Primarily relates to interest rate swaps. Included in Other current liabilities.

(4) Included in Other current liabilities and Other long-term liabilities.

A reconciliation of the beginning and ending balances for Level 3 liabilities follows (in millions):

The estimated fair value of the Company’s debt, including current maturities, was based on Level 2 inputs, being market quotes or values for similar instruments, and interest rates currently available to the Company for the issuance of debt with similar terms and remaining maturities as a discount rate for the remaining principal payments. As of September 8, 2018, the fair value of total debt was $10,788.8 million compared to the carrying value of $11,248.5 million, excluding debt discounts and deferred financing costs. As of February 24, 2018, the fair value of total debt was $10,603.4 million compared to the carrying value of $11,340.5 million, excluding debt discounts and deferred financing costs.

Assets Measured at Fair Value on a Non-Recurring Basis

The Company measures certain assets at fair value on a non-recurring basis, including long-lived assets and goodwill, which are evaluated for impairment. Long-lived assets include store-related assets such as property and equipment and certain intangible assets. The inputs used to determine the fair value of long-lived assets and a reporting unit are considered Level 3 measurements due to their subjective nature.

NOTE 4 - DERIVATIVE FINANCIAL INSTRUMENTS

Interest Rate Risk Management

The Company is exposed to market risk from fluctuations in interest rates. The Company manages its exposure to interest rate fluctuations through the use of interest rate swaps ("cash flow hedges"). The Company’s risk management objective and strategy with respect to interest rate swaps is to protect the Company against adverse fluctuations in interest rates by reducing its exposure to variability in cash flows relating to interest payments on a portion of its outstanding debt. The Company is meeting its objective by hedging the risk of changes in its cash flows (interest payments) attributable to changes in the London Inter-Bank Offering Rate ("LIBOR"), the designated benchmark interest rate being hedged (the "hedged risk"), on an amount of the Company's debt principal equal to the then-outstanding swap notional amount.

Cash Flow Interest Rate Swaps

For derivative instruments that are designated and qualify as cash flow hedges of forecasted interest payments, the Company reports the gain or loss as a component of Other comprehensive income until the interest payments being hedged are recorded as Interest expense, net, at which time the amounts in Other comprehensive income are reclassified as an adjustment to Interest expense, net. The Company has entered into several swaps with maturity dates in 2019 and 2021 to hedge against variability in cash flows relating to interest payments on a portion of the Company's outstanding variable rate term debt. The aggregate notional amounts of all swaps as of both September 8, 2018 and February 24, 2018 were $3,110.0 million, of which $3,052.0 million are designated as cash flow hedges as defined by GAAP. The undesignated portion of the Company's interest rate swaps is attributable to principal payments expected to be made through the loan’s maturity.

On June 20, 2018, the Company entered into two new interest rate swap agreements with notional amounts of $339.0 million and $254.0 million, with an effective date of March 2019 and maturing in March 2023. These swaps hedge against variability in cash flows relating to interest payments on the Company’s outstanding variable rate debt. Accordingly, the interest rate swaps will be designated as cash flow hedges as defined by GAAP.

As of September 8, 2018, and February 24, 2018, the fair value of the cash flow interest rate swap liability was $1.6 million and $13.0 million, respectively, and was recorded in Other current liabilities.

Activity related to the Company’s derivative instruments designated as cash flow hedges consisted of the following (in millions):

Activity related to the Company’s derivative instruments not designated as hedging instruments was immaterial during the 12 and 28 weeks ended September 8, 2018 and September 9, 2017, respectively.

The Company's term loans (the "Albertsons Term Loans"), asset-based loan ("ABL") facility (the "ABL Facility") and certain of the outstanding notes and debentures have restrictive covenants, subject to the right to cure in certain circumstances, calling for the acceleration of payments due in the event of a breach of a covenant or a default in the payment of a specified amount of indebtedness due under certain debt arrangements. There are no restrictions on the Company's ability to receive distributions from its subsidiaries to fund interest and principal payments due under the ABL Facility, the Albertsons Term Loans and the Company's senior unsecured notes (the "Senior Unsecured Notes"). Each of the ABL Facility, Albertsons Term Loans and the Senior Unsecured Notes restrict the ability of the Company to pay dividends and distribute property to the Company's stockholders. As a result, all of the Company's consolidated net assets are effectively restricted with respect to their ability to be transferred to the Company's stockholders. Notwithstanding the foregoing, the ABL Facility, Albertsons Term Loans and the Senior Unsecured Notes each contain customary exceptions for certain dividends and distributions, including the ability to make cumulative distributions under the Albertsons Term Loans and Senior Unsecured Notes of up to the greater of $1.0 billion or 4% of the Company's total assets (which is measured at the time of such distribution) and the ability to make distributions if certain payment conditions are satisfied under the ABL Facility. The Company was in compliance with all such covenants and provisions as of and for the 28 weeks ended September 8, 2018.

Asset-Based Loan Facility

As of September 8, 2018 and February 24, 2018, there were no loans outstanding under the Company's ABL Facility, and letters of credit ("LOC") issued under the LOC sub-facility were $547.6 million and $576.8 million, respectively.

Capitalized Lease Obligations

The Company's capitalized lease obligations were $818.5 million and $864.6 million as of September 8, 2018 and February 24, 2018, respectively. Current maturities of capitalized lease obligations were $104.1 million and $102.1 million and long-term maturities were $714.4 million and $762.5 million as of September 8, 2018 and February 24, 2018, respectively.

Merger Related Financing

On June 25, 2018 the Company issued $750.0 million in aggregate principal amount of floating rate senior secured notes (the "Floating Rate Notes") at an issue price of 99.5%. As a result of the Termination Agreement with Rite Aid

on August 8, 2018, the Company redeemed all of the Floating Rate Notes at a redemption price equal to 99.5% of the aggregate principal amount of the notes, plus accrued and unpaid interest.

The Company contributed $5.0 million and $10.5 million to its defined benefit pension plans and post-retirement benefit plans during the 12 and 28 weeks ended September 8, 2018, respectively. For the 12 and 28 weeks ended September 9, 2017, the Company contributed $4.3 million and $6.4 million to its defined benefit pension plans and post-retirement benefit plans, respectively. The Company's funding policy for the defined benefit pension plans is to contribute the minimum contribution required under the Employee Retirement Income Security Act of 1974, as amended, and other applicable laws as determined by the Company's external actuarial consultant. At the Company's discretion, additional funds may be contributed to the defined benefit pension plans. On September 14, 2018, subsequent to the end of the second quarter, the Company contributed $184.3 million to its defined benefit pension plans, which included $150.0 million of additional discretionary contributions to reduce the Pension Benefit Guaranty Corporation premium costs and improve the overall funded status of the plan. The Company currently anticipates contributing an additional $4.6 million to these plans for the remainder of fiscal 2018.

The Company also contributes to various multiemployer pension plans based on obligations arising from most of its collective bargaining agreements. These plans provide retirement benefits to participants based on their service to contributing employers. The Company recognizes expense in connection with these plans as contributions are funded.

Defined Contribution Plans and Supplemental Retirement Plans

Many of the Company's employees are eligible to contribute a percentage of their compensation to defined contribution plans ("401(k) Plans"). Participants in the 401(k) Plans may become eligible to receive a profit-sharing allocation in

the form of a discretionary Company contribution based on employee compensation. In addition, the Company may also provide matching contributions based on the amount of eligible compensation contributed by the employee. All Company contributions to the 401(k) Plans are made at the discretion of the Company's Board of Directors. Total contributions expensed for these plans were $6.5 million and $9.6 million for the 12 weeks ended September 8, 2018 and September 9, 2017, respectively. For the 28 weeks ended September 8, 2018 and September 9, 2017, total contributions expensed were $20.5 million and $23.2 million, respectively.

NOTE 8 - COMMITMENTS AND CONTINGENCIES AND OFF BALANCE SHEET ARRANGEMENTS

Guarantees

California Department of Industrial Relations: On October 24, 2012, the Office of Self-Insurance Plans, a program within the director's office of the California Department of Industrial Relations (the "DIR"), notified SuperValu, which was then the owner of NALP, a wholly-owned subsidiary of the Company, that additional collateral was required to be posted in connection with the Company's, and certain other subsidiaries', California self-insured workers’ compensation obligations pursuant to applicable regulations. The notice from the DIR stated that the additional collateral was required as a result of an increase in estimated future liabilities, as determined by the DIR pursuant to a review of the self-insured California workers' compensation claims with respect to the applicable businesses, and a decline in SuperValu’s net worth. On January 21, 2014, the Company entered into a Collateral Substitution Agreement with the California Self-Insurers' Security Fund to provide an irrevocable LOC. The amount of the LOC is adjusted semi-annually based on semi-annual filings of an actuarial study reflecting liabilities as of and June 30 and December 31 of each year reduced by claim closures and settlements. The related LOC was $183.0 million and $205.6 million as of September 8, 2018 and February 24, 2018, respectively.

Lease Guarantees: The Company may have liability under certain operating leases that were assigned to third parties. If any of these third parties fail to perform their obligations under the leases, the Company could be responsible for the lease obligation. Because of the wide dispersion among third parties and the variety of remedies available, the Company believes that if an assignee became insolvent, it would not have a material effect on the Company's financial condition, results of operations or cash flows.

The Company also provides guarantees, indemnifications and assurances to others in the ordinary course of its business.

Legal Proceedings

The Company is subject from time to time to various claims and lawsuits arising in the ordinary course of business, including lawsuits involving trade practices, lawsuits alleging violations of state and/or federal wage and hour laws (including alleged violations of meal and rest period laws and alleged misclassification issues), real estate disputes as well as other matters. Some of these suits purport or may be determined to be class actions and/or seek substantial damages. It is the opinion of the Company's management that although the amount of liability with respect to certain of the matters described herein cannot be ascertained at this time, any resulting liability of these and other matters, including any punitive damages, will not have a material adverse effect on the Company's business or financial condition.

The Company continually evaluates its exposure to loss contingencies arising from pending or threatened litigation and believes it has made provisions where the loss contingency can be reasonably estimated and an adverse outcome is probable. Nonetheless, assessing and predicting the outcomes of these matters involves substantial uncertainties. Management currently believes that the aggregate range of reasonably possible loss for the Company's exposure in excess of the amount accrued is expected to be immaterial to the Company. It remains possible that despite management's current belief, material differences in actual outcomes or changes in management’s evaluation or predictions could arise that could have a material effect on the Company's financial condition, results of operations or cash flows.

Litigation Related to the Rite Aid Merger: On April 24, 2018, Mel Aklile, a Rite Aid stockholder, (the "Plaintiff") brought a putative class action in Delaware Chancery Court against Rite Aid, the Company, certain of the Company's subsidiaries and each of the Rite Aid directors, Del. C.A. No. 2018-0305-AGB. The complaint alleged that Rite Aid stockholders had appraisal rights under Section 262 of the Delaware General Corporate Law ("DGCL"). The defendants opposed the Plaintiff's claims on the ground that Rite Aid stockholders had no right of appraisal under the DGCL because they had a right to receive all stock consideration as described in the proxy statement/prospectus filed by the Company on April 6, 2018. On May 7, 2018, the Chancery Court held a hearing on the Plaintiff's motion to expedite, finding that the Plaintiff failed to assert a colorable claim of relief. On May 16, 2018, the defendants filed motions to dismiss the Plaintiff's complaint. On August 8, 2018, while defendants' motions to dismiss were still pending and before any putative class had been certified, the Company and Rite Aid mutually agreed to terminate the proposed transaction thereby mooting the Plaintiff's claims. As a result, Mr. Aklile and defendants stipulated to the dismissal action with prejudice and with each party agreeing to bear its own fees and expenses, which the Chancery Court granted on August 14, 2018.

Office of Inspector General: In January 2016, the Company received a subpoena from the Office of the Inspector General of the Department of Health and Human Services (the "OIG") pertaining to the pricing of drugs offered under the Company’s MyRxCare discount program and the impact on reimbursements to Medicare, Medicaid and TRICARE (the "Government Health Programs"). In particular, the OIG is requesting information on the relationship between the prices charged for drugs under the MyRxCare program and the "usual and customary" prices reported by the Company in claims for reimbursements to the Government Health Programs or other third-party payors. The Company is cooperating with the OIG in the investigation. The Company is currently unable to determine the probability of the outcome of this matter or the range of reasonably possible loss, if any.

Civil Investigative Demand: On December 16, 2016, the Company received a civil investigative demand from the United States Attorney for the District of Rhode Island in connection with a False Claims Act investigation relating to the Company's influenza vaccination programs. The investigation concerns whether the Company's provision of store coupons to its customers who received influenza vaccinations in its store pharmacies constituted an improper benefit to those customers under the federal Medicare and Medicaid programs. The Company believes that its provision of the store coupons to its customers is an allowable incentive to encourage vaccinations. The Company is cooperating with the U.S. Attorney in the investigation. The Company is currently unable to determine the probability of the outcome of this matter or the range of possible loss, if any.

Security Breach: On August 14, 2014, the Company announced that it had experienced a criminal intrusion by installation of malware on a portion of its computer network that processes payment card transactions for its retail store locations, including the Company's Shaw’s, Star Market, Acme, Jewel-Osco and Albertsons retail banners. On September 29, 2014, the Company announced that it had experienced a second and separate criminal intrusion. The Company believes these were attempts to collect payment card data. Relying on its IT service provider, SuperValu, the Company took immediate steps to secure the affected part of the network. The Company believes that it has eradicated the malware used in each intrusion. The Company notified federal law enforcement authorities, the major payment card networks and its insurance carriers and is cooperating in their efforts to investigate these intrusions. As required by the payment card brands, the Company retained a firm to conduct a forensic investigation into the intrusions. The forensic firm has issued separate reports for each intrusion (copies of which have been provided to the card networks). Although the Company's network had previously been found to be compliant with the Payment Card Industry (PCI) Data Security Standard issued by the PCI Council, in both reports the forensic firm found that not all of these standards had been met at the time of the intrusions, and some of this non-compliance may have contributed to or caused at least some portion of the compromise that occurred during the intrusions.

On August 5, 2016, the Company was notified that MasterCard had asserted its initial assessment for incremental counterfeit fraud losses and non-ordinary course expenses (such as card reissuance costs) as well as a case management assessment. On December 5, 2016, the Company was further notified that MasterCard had asserted its final assessment of approximately $6.0 million, which the Company paid on December 9, 2016; however, the Company disputes the MasterCard assessment and, on March 10, 2017, filed a lawsuit against MasterCard seeking recovery of the assessment. On May 5, 2017, MasterCard filed a motion to dismiss the litigation. In a decision dated August 25, 2017, the court denied MasterCard's motion, and the litigation is ongoing. On January 2, 2018, the Company was notified that Visa, Inc. ("Visa") had asserted its assessment for incremental counterfeit fraud losses and card reissuance costs for $1.0 million, which the Company paid in the fourth quarter of fiscal 2017. The Company has recorded an estimated liability for any remaining potential claims from other card networks.

 

As a result of the criminal intrusions, two class action complaints were filed against the Company by consumers, Mertz v. SuperValu Inc. et al, filed in federal court in the state of Minnesota and Rocke v. SuperValu Inc. et al, filed in federal court in the state of Idaho, alleging deceptive trade practices, negligence and invasion of privacy. The plaintiffs seek unspecified damages. The Judicial Panel on Multidistrict Litigation has consolidated the class actions and transferred the cases to the District of Minnesota. On August 10, 2015, the Company and SuperValu filed a motion to dismiss the class actions, which was granted without prejudice on January 7, 2016. The plaintiffs filed a motion to alter or amend the court's judgment, which was denied on April 20, 2016. The court also denied leave to amend the complaint. On May 18, 2016, the plaintiffs filed a notice of appeal to the Eighth Circuit Court of Appeals and defendants filed a cross-appeal. In a decision dated August 30, 2017, the Eighth Circuit Court of Appeals reversed the District Court's dismissal of the case as to one of the 16 named plaintiffs, affirmed the dismissal as to the remaining 15 named plaintiffs and remanded the case to the District Court for further proceedings. On November 3, 2017, the Company filed a motion to dismiss with respect to the remaining named plaintiff's claims on the basis that the plaintiff was not a customer of any of the Company's stores, and on March 7, 2018, the Company's motion to dismiss was granted with prejudice. On March 14, 2018, the named plaintiffs filed a notice of appeal to the Eight Circuit Court of Appeals. The appeal is currently pending.

On October 6, 2015, the Company received a letter from the Office of Attorney General of the Commonwealth of Pennsylvania stating that the Illinois and Pennsylvania Attorneys General Offices are leading a multi-state group that includes the Attorneys General for 14 other states requesting specified information concerning the two data breach incidents. The multi-state group has not made a monetary demand, and the Company is unable to estimate the possibility of or reasonable range of loss, if any. The Company is cooperating with the investigation. Two of the Company's insurance carriers have denied the Company's claim for cyber insurance coverage for losses resulting from the intrusions based on, among other things, the insurers’ conclusions that the intrusions began prior to the start date for coverage

under the cyber insurance policy. The Company responded to the insurers’ denials disagreeing with the conclusions and reserving its rights. The Company's claims with other of its insurance carriers remain outstanding.

Terraza/Lorenz: Two lawsuits have been brought against Safeway and the Safeway Benefits Plan Committee (the "Benefit Plans Committee," and together with Safeway, the "Safeway Benefits Plans Defendants") and other third parties alleging breaches of fiduciary duty under the Employee Retirement Income Security Act of 1974, as amended ("ERISA") with respect to Safeway’s 401(k) Plan (the "Safeway 401(k) Plan"). On July 14, 2016, a complaint ("Terraza") was filed in the United States District Court for the Northern District of California by a participant in the Safeway 401(k) Plan individually and on behalf of the Safeway 401(k) Plan. An amended complaint was filed on November 18, 2016. On August 25, 2016, a second complaint ("Lorenz") was filed in the United States District Court for the Northern District of California by another participant in the Safeway 401(k) Plan individually and on behalf of all others similarly situated against the Safeway Benefits Plans Defendants and against the Safeway 401(k) Plan’s former recordkeepers. An amended complaint was filed on September 16, 2016, and a second amended complaint was filed on November 21, 2016. In general, both lawsuits allege that the Safeway Benefits Plans Defendants breached their fiduciary duties under ERISA regarding the selection of investments offered under the Safeway 401(k) Plan and the fees and expenses related to those investments. The Company believes these lawsuits are without merit and intends to contest each of them vigorously. The Safeway Benefits Plans Defendants have filed motions to dismiss both cases. The Company is currently unable to estimate the range of loss, if any, that may result from these matters. On March 13, 2017, the United States District Court for the Northern District of California denied the Safeway Benefits Plan Defendants' motion to dismiss with respect to Terraza, and granted in part and denied in part the Safeway Benefits Plan Defendants' motion to dismiss with respect to Lorenz. On December 12, 2017, the Court in Terraza denied in part and granted in part a motion to dismiss brought by co-defendant Aon Hewitt. Fact discovery closed on April 22, 2018, and expert discovery closed on June 8, 2018. The parties filed summary judgment motions on June 28, 2018 which were heard and taken under submission on August 16, 2018. Bench trials for both matters had been set for October 22, 2018, but the judge recently motioned to reschedule both trials to May 6, 2019. Because the question of liability, if any, is uncertain, the Company is currently unable to estimate a range of reasonably possible loss, if any, that may result from these matters

False Claims Act: Three qui tam actions have been filed against the Company under the False Claims Act. In United States ex rel. Schutte and Yarberry v. SuperValu, New Albertson's, Inc. ("Albertsons"), et al, the relators allege that defendants (including various Albertsons subsidiaries) overcharged federal healthcare programs by not providing the government, as a part of usual and customary prices, the benefit of discounts given to customers who requested that defendants match competitor prices. The complaint was originally filed under seal and amended on November 30, 2015. Both sides have moved for summary judgment, and motions are pending before the court. Trial is set for December 3, 2018. In United States ex rel. Proctor v. Safeway, the relator alleges that Safeway submitted fraudulent, inflated pricing information to government healthcare programs in connection with prescription drug claims, by failing to include pharmacy discount program pricing as a part of its usual and customary prices. On August 26, 2015, the underlying complaint was unsealed. Relators filed an amended complaint, and Safeway’s motion to dismiss the amended complaint was denied. Discovery is ongoing, and trial is currently set for March 4, 2019. In United States ex rel. Zelickowski v. Albertsons LLC, relators alleges that Albertsons overcharged federal healthcare programs by not providing the government, as a part of its usual and customary prices to the government, the benefit of discounts given to customers who enrolled in Albertsons’ discount-club program. The complaint was originally filed under seal and amended on June 20, 2017. Albertsons filed a motion to dismiss the case in August 2018, which is now fully briefed and pending before the court. The government previously investigated the relators' allegations in each of the cases and declined to intervene in any of the cases. Relators elected to pursue their respective cases on their own, and the Company is vigorously defending each of those matters. At this stage of each case's proceedings the Company is unable to express an opinion with respect to the likelihood of an unfavorable outcome or to estimate the amount or range of potential loss, if any, if the outcome of any of them should be unfavorable.